These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9695698)
1. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study. Pinnock CB; Weller DP; Marshall VR Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698 [TBL] [Abstract][Full Text] [Related]
2. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. Dyche DJ; Ness J; West M; Allareddy V; Konety BR J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807 [TBL] [Abstract][Full Text] [Related]
4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796 [TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark. Jønler M; Eddy B; Poulsen J Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day). Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579 [TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate cancer screening among health fair participants. Chiu BC; Anderson JR; Corbin D Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? O'Dell KJ; Volk RJ; Cass AR; Spann SJ J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. Bunting PS; Goel V; Williams JI; Iscoe NA CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349 [TBL] [Abstract][Full Text] [Related]
10. Self-reported prostate cancer screening in Austria. Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656 [TBL] [Abstract][Full Text] [Related]
11. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history. McDowell ME; Occhipinti S; Gardiner RA; Chambers SK BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681 [TBL] [Abstract][Full Text] [Related]
13. Age-specific patterns of prostate-specific antigen testing among primary care physician visits. McNaughton Collins M; Stafford RS; Barry MJ J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of PSA testing and effect of clinical indications on patterns of PSA testing in a population-based sample of Alberta men. McGregor SE; Bryant HE; Brant RF; Corbett PJ Chronic Dis Can; 2002; 23(3):111-9. PubMed ID: 12443567 [TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam. Beemsterboer PM; de Koning HJ; Kranse R; Trienekens PH; van der Maas PJ; Schröder FH J Urol; 2000 Oct; 164(4):1216-20. PubMed ID: 10992369 [TBL] [Abstract][Full Text] [Related]
17. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening. Gattellari M; Ward JE J Med Screen; 2004; 11(4):165-9. PubMed ID: 15563771 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091 [TBL] [Abstract][Full Text] [Related]
19. Intention to test for prostate cancer. Berglund G; Nilsson S; Nordin K Eur J Cancer; 2005 May; 41(7):990-7. PubMed ID: 15862747 [TBL] [Abstract][Full Text] [Related]
20. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK. Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]